SCHEMBL31438737

SCHEMBL31438737

CCCCCCCC(CCCCCCC)OC(=O)CCCCCC(=O)OCC(COC(=O)CCCCCC(=O)OC(CCCCCCC)CCCCCCC)COC(=O)CCCN1CCCC1

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.56
▸ LMNA P02545 1/20 0.56
▸ PRKCA P17252 2/20 0.52
▸ PRKCE Q02156 2/20 0.52
▸ PRKCQ Q04759 2/20 0.52
▸ PRKCD Q05655 2/20 0.52
▸ LPAR3 Q9UBY5 6/20 0.47
▸ LPAR1 Q92633 3/20 0.47
▸ ENPP2 Q13822 3/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ TLR2 O60603 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ LPAR2 Q9HBW0 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25132703 0.94 ALDH1A1 (0.52) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL15027809 0.92 ALDH1A1 (0.50) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL27425698 0.92 ALDH1A1 (0.49) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL15027738 0.91 ALDH1A1 (0.49) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL27425705 0.91 ALDH1A1 (0.48) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL27425710 0.90 ALDH1A1 (0.47) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL27425713 0.89 ALDH1A1 (0.47) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL15027551 0.89 ALDH1A1 (0.50) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL17123891 0.89 ALDH1A1 (0.50) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL15027872 0.89 ALDH1A1 (0.50) ALDH1A1LMNAPRKCAPRKCEPRKCQ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025038864-A1 IONIZABLE LIPIDS WITH LINEAR HEAD GROUPS BEAM THERAPEUTICS INC. (US) 2025-02-20 — — WO disclosed
Send feedback